Refine
Has Fulltext
- yes (43)
Is part of the Bibliography
- yes (43)
Year of publication
- 2012 (43) (remove)
Document Type
- Doctoral Thesis (43) (remove)
Keywords
- Drosophila (4)
- Taufliege (4)
- Vaccinia-Virus (4)
- vaccinia virus (4)
- Apoptosis (3)
- Melanom (3)
- Myc (3)
- Netzwerkanalyse (3)
- oncolytic virotherapy (3)
- onkolytische Virotherapie (3)
Institute
- Theodor-Boveri-Institut für Biowissenschaften (43) (remove)
Cancer-related anemia is prevalent in cancer patients. Anemia negatively affects normal mental and physical function capacity with common symptoms s like fatigue, headache, or depression. Human erythropoietin (hEPO), a glycoprotein hormone regulating red blood cell formation, is approved for the treatment of cancer-related anemia. It has shown benefits in correcting anemia, and subsequently improving health-related quality of life and/or enhancing radio-, and chemotherapy. Several recent clinical trials have suggested that recombinant hEPO (rhEPO) may promote tumor growth that raises the questions concerning the safety of using rhEPO for cancer treatment. However in others, such effects were not indicated. As of today, the direct functional effect of rhEPO in tumor models remains controversial and needs to be further analyzed. Based on the GLV-1h68 backbone, the hEPO-expressing recombinant VACV strains (EPO-VACVs) GLV-1h210, GLV-1h211, GLV-1h212 and GLV-1h213 were generated by replacing the lacZ expression cassette at the J2R locus with hEPO under the control of different vaccinia promoters p7.5, pSE, pSEL, pSL, respectively. Also, GLV-1h209 was generated, which is similar to GLV-1h210 but expresses a mutated non-functinal EPO (R103A). The EPO-VACV strains were characterized for their oncolytic efficacy in lung (A549) cancer cells in culture and tumor xenografts. Concomitantly, the effects of locally expressed hEPO in tumors on virus replication, host immune infiltration, tumor vascularization and tumor growth were also evaluated. As expected, EPO-VACVs enhanced red blood cell (RBC) formation in xenograft model. The number of RBCs and hemoglobin (Hb) levels were significantly increased in EPO-VACVs-treated mice compared to GLV-1h68-treated or untreated control mice. However, the mean size of RBC or Hb content per RBC remained normal. Furthermore, over-expression of hEPO did not significantly affect numbers of lymphocytes, monocytes, leucocytes or platelets in the peripheral blood stream. The expression of hEPO in colonized tumors of mice treated with EPO-VACVs was demonstrated by immunohistological staining. Interestingly, there were 9 - 10 hEPO isoforms detected either in tumors, cells, or supernatant, while 3-4 basic isoforms were missing in blood serum, where only six hEPO isoforms were found. Tumor-bearing mice after treatment with EPO-VACVs showed enhanced tumor regression compared to GLV-1h68. The virus titers in tumors in EPO-VACVs-treated mice were 3-4 fold higher compared to GLV-1h68-treated mice. Nevertheless, no significant difference in virus titers among EPO-VACVs was found. The blood vessels in tumors were significantly enlarged while the blood vessel density remained unchanged compared to the GLV-1h68 treated mice, indicating that hEPO did not affect endothelial cell proliferation in this model. Meanwhile, rhEPO (Epoetin alfa) alone or in combination with GLV-1h68 did not show any signs of enhanced tumor growth when compared to untreated controls and GLV-1h68 groups, while doses used were clinical relevant (500 U/kg). These findings suggested that hEPO did not promote angiogenesis or tumor growth in the A549 tumor xenograft model. Human EPO has been reported to function as an immune modulator. In this study, however, we did not find any involvement of hEPO in immune cytokine and chemokine expression or innate immune cell infiltration (leucocytes, B cells, macrophages and dendritic cells) into infected tumors. The degree of immune infiltration and cytokine expression was directly correlated to the number of virus particles. Increased virus replication, led to more recruited immune cells and secreted cytokines/chemokines. It was proposed that tumor regression was at least partially mediated through activation of innate immune mechanisms. In conclusion, the novel EPO-VACVs were shown to significantly increase the number of RBCs, Hb levels, and virus replication in tumors as well as to enhance tumor regression in the A549 tumor xenograft model. Moreover, locally expressed hEPO did not promote tumor angiogenesis, tumor growth, and immune infiltration but was shown to causing enlarged tumoral microvessels which facilitated virus spreading. It is conceivable that in a possible clinical application, anemic cancer patients could benefit from the EPO-VACVs, where they could serve as “wellness pills” to decrease anemic symptoms, while simultaneously destroying tumors.
Das menschliche Genom verschlüsselt 30000 bis 40000 Proteine, von denen ein Großteil kovalent gebundene Karbohydrat-Gruppen an Asparagin-, Serin-, Threonin- oder Hydroxylysin-Resten trägt. Diese sogenannten Glykoproteine sind allgegenwärtige Bestandteile der extrazellulären Matrix von Zelloberflächen. Sie steuern Zell-Zell- und Zell-Matrix-Kommunikationen, können bei der roteinfaltung helfen bzw. die Proteinstabilität erhöhen oder Immunantworten regulieren. Die Auslösung von biologischen Prozesse erfordert aber Übersetzer der zuckerbasierten Informationen. Solche Effektoren sind die Lektine, unter ihnen auch die Galektine. Galektine binden spezifisch β-Galaktosen, weisen strukturelle Übereinstimmungen in der Aminosäuresequenz ihrer Zuckererkennungsdomänen (CRDs) auf und zeigen ein „jelly-roll“-Faltungsmuster, bestehend aus einem β-Sandwich mit zwei antiparallelen Faltblättern. Strukturell werden die CRDs in drei verschiedenen, topologischen Formen präsentiert. Proto-Typen existieren als nicht-kovalent verknüpfte Dimere der CRDs, Chimera-Typen besitzen neben der CRD eine Nicht-Lektin-Domäne und bei den Tandem-Repeat-Typen sind zwei verschiedene CRDs über ein kurzes Linker-Peptid kovalent verbunden. Galektine werden sowohl in normalem wie auch pathogenem Gewebe exprimiert und das zunehmende Wissen über die Beteiligung an verschiedenen Krankheiten und Tumorwachstum liefert die Motivation, strukturelle Aspekte und die Vernetzung von Lektinen detailliert, insbesondere im Hinblick auf ihre intrafamiliären Unterschiede, zu untersuchen. Durch die Kombination verschiedener Spektroskopie-Techniken mit hoher zeitlicher und räumlicher Auflösung, basierend auf der Verwendung von Fluorophoren (intrinsisch und extrinsisch), werden in dieser Arbeit die Eigenschaften von Galektinen näher untersucht. Mit Fluoreszenz-Korrelations-Spektroskopie (FCS) und Anisotropie-Messungen wird gezeigt, dass eine Liganden-Bindung bei Proto-Typ-Galektinen mit einer Verringerung des hydrodynamischen Radius einhergeht. Bei Tandem-Repeat- und Chimera-Typen bleibt der Radius konstant. Dafür skaliert die Diffusionskonstante von Tandem-Repeat-Typen anormal mit der molaren Masse. Die Anisotropie-Messungen werden parallel zu den FCS-Messungen durchgeführt, um einen Einfluss des Fluoreszenzmarkers auszuschließen. Mit Hilfe dieser Technik wird außerdem gezeigt, dass unterschiedliche Dissoziationskonstanten und Kinetiken für den Bindungsprozess innerhalb der Proto-Typ-Gruppe möglichweise auf unterschiedliche Konformationsdynamiken zurückgehen. Der Vergleich von hGal-1 und cG-1B verdeutlicht, dass strukturelle Ähnlichkeiten zwar ein identisches Bindungsverhalten hervorrufen können, der Oxidationsprozess der Proteine aber unterschiedlich ablaufen kann. Beide Methoden können so als sehr sensitive Techniken zur Untersuchung von Strukturmerkmalen bei Galektinen etabliert werden, wobei die Übertragbarkeit auf andere Glykoproteine gewährleistet ist. Weiterhin gilt Quervernetzung als eine der wichtigsten Eigenschaften von Galektinen, da durch die Vernetzung von Glykoproteinen auf der Zelloberfläche Signalwege aktiviert und Immunantworten reguliert werden. Um die räumliche organisation und Quervernetzung von hGal-1 auf den Oberflächen von Neuroblastomzellen nachzuweisen, eignet sich das hochauflösende Mikroskopieverfahren dSTORM sehr gut. Durch Verwendung des photoschaltbaren Fluorophors Alexa647 als spezifischem Marker für hGal-1, einem Standard-Weitfeld-Aufbau und verschiedenen Analyseverfahren, kann eine Clusterformation von hGal-1 auf der Zelloberfläche bestätigt werden. hGal-1 bildet Cluster mit einem mittleren Durchmesser von 81±7 nm aus. Der Durchmesser ist unabhängig von der Konzentration, während die Anzahl der Cluster davon abhängt. Für die Clusterausbildung ist ein Startpunkt, also eine minimale Dichte der Galektin-Moleküle, notwendig. Durch Blockierung der CRDs mit Laktose wird die Clusterbildung unterdrückt und die Spezifität der CRDs gegenüber β-Galaktosen erneut herausgestellt. Anders als dimeres hGal-1 binden Monomere deutlich schlechter an die Membranrezeptoren. Es werden keine Cluster ausgebildet, eine Quervernetzung von Membranrezeptoren ist nicht möglich. Außerdem kann es durch die Monomere zu einer vollständigen Markierung und damit Abkugellung der Zellen kommen. Möglicherweise wird der Zelltod induziert. Hochauflösende Mikroskopieverfahren sind durch den Markierungsprozess limitiert. Die bioorthogonale Click-Chemie eröffnet jedoch neue Möglichkeiten zur Markierung und Visualisierung von Biomolekülen, ohne die Notwenigkeit genetischer Manipulationen. Es werden modifizierte Zuckermoleküle in die Zellmembranen eingebaut, über eine 1,3-polare Cycloaddition mit einem Alkin markiert und ihre Verteilung mit Hilfe von dSTORM untersucht. Es wird nachgewiesen, dass die Zuckermoleküle in Clustern auftreten und Click-Chemie trotz dem Katalysator Kupfer an lebenden Zellen durchführbar ist. Die Bewegung der Gesamtcluster wird mittels Mean Square Displacement aufgeschlüsselt und eine Diffusionskonstante für Cluster im Bereich von 40 - 250 nm bestimmt. Zusammenfassend stellt die Kombination verschiedener Spektroskopie-Techniken ein gutes Werkzeug zur Untersuchung von Karbohydrat-bindendenden Proteinen mit hoher räumlicher und zeitlicher Auflösung dar und ermöglicht einen neuen Einblick in die Biologie der Galektine.
Hintergrund: Das Absterben Neuromelanin (NM)-haltiger Zellen in der substantia nigra (SN), und die daraus resultierende Erniedrigung des Dopaminspiegels im striatum, ist ein pathologisches Hauptmerkmal der Parkinsonschen Krankheit. Ein neuerlicher Nachweis von Anti-Melanin-Antikörpern gibt Anlass zur Vermutung, dass NM ein Autoantigen sein könnte. In dieser Arbeit wurde gezeigt, dass NM tatsächlich von dendritischen Zellen (DZ), die in vivo hauptverantwortlich für die Auslösung von T- und B-Zellantworten sind, erkannt wird. Die Erkennung von NM durch DZ ist eine unabdingbare Voraussetzung für die Einleitung einer adaptiven Immunantwort. Methoden: Murine dendritische Zellen (mDZ) wurden aus Knochenmarkszellen generiert und mit NM aus humaner SN oder synthetischem Dopaminmelanin (DAM) behandelt, nachdem beide Melanine endotoxinfrei getestet wurden. Die Phagozytose von NM wurde mittels konfokaler Mikroskopie dokumentiert. Die Expression von MHC II und CD86 wurde mittels Durchflusszytometrie (FACS) analysiert. Zytokinkonzentrationen von TNF- und dem Interleukin IL-6 wurden mit ELISA-Assays bestimmt. Abschließend wurde die Funktion der durch NM aktivierten DZ mit einer allogenen mixed lymphocyte reaction (MLR) überprüft. Ergebnisse: NM wurde von den mDZ effektiv phagozytiert, woraufhin die mDZ einen reifen Phenotyp (CD86high/MHC IIhigh) zeigten. Zusätzlich sekretierten durch NM aktivierte mDZ die Zytokine IL-6 and TNF-. Schließlich ließen die mDZ T-Zellen in einer MLR proliferieren, und beweisen so ihre Funktionalität und die Fähigkeit eine primäre T-Zellantwort auszulösen. Im Gegenteil dazu konnte DAM, dem die Protein- und Lipidkomponenten von NM fehlen und nur das Melaninrückrat mit NM gemeinsam hat, nur einen kleinen Effekt bei den mDZ hervorrufen. Diskussion: NM wird von DZ in vitro erkannt und bewirkt deren Reifung. Sollte der Vorgang auch in vivo stattfinden, besteht die Möglichkeit, dass SN-Antigene dem adaptiven Immunsystem präsentiert werden, was in einzelnen Fällen zur Einleitung einer adaptiven Immunantwort führen könnte. NM könnte also der Auslöser für einen autoimmunen Pathomechanismus in der parkinsonschen Krankheit sein.
In this thesis the Drosophila mutant loechrig (loe), that shows progressive degeneration of the nervous system, is further described. Loe is missing a neuronal isoform of the protein kinase AMPK γ subunit (AMP-activated protein kinase- also known as SNF4Aγ) The heterotrimeric AMPK controls the energy level of the cell, which requires constant monitoring of the ATP/AMP levels. It is activated by low energy levels and metabolic insults like oxygen starvation and regulates multiple important signal pathways that control cell metabolism. Still, its role in neuronal survival is unclear. One of AMPK’s downstream targets is HMGR (hydroxymethylglutaryl-CoA- reductase), a key enzyme in cholesterol and isoprenoid synthesis. It has been shown that manipulating the levels of HMGR affects the severity of the neurodegenerative phenotype in loe. Whereas the regulatory role of AMPK on HMGR is conserved in Drosophila, insects cannot synthesize cholesterol de novo. However, the synthesis of isoprenoids is a pathway that is evolutionarily conserved between vertebrates and insects. Isoprenylation of target proteins like small G-proteins provides a hydrophobic anchor that allows the association of these proteins with membranes and following activation. This thesis shows that the loe mutation interferes with the prenylation of Rho1 and the regulation of the LIM kinase pathway, which plays an important role in actin turnover and axonal outgrowth. The results suggest that the mutation in LOE, causes hyperactivity of the isoprenoid synthesis pathway, which leads to increased farnesylation of RHO1 and therefore higher levels of phospho-cofilin. A mutation in Rho1 improves the neurodegenerative phenotype and life span. The increased inactive cofilin amount in loe leads to an up regulation of filamentous actin. Actin is involved in neuronal outgrowth and experiments analyzing loe neurons gave valuable insights into a possible role of AMPK and accordingly actin on neurite growth and stability. It was demonstrated that neurons derived from loe mutants exhibit reduces axonal transport suggesting that changes in the cytoskeletal network caused by the effect of loe on the Rho1 pathway lead to disruptions in axonal transport and subsequent neuronal death. It also shows that actin is not only involved in neuronal outgrowth, its also important in maintenance of neurons, suggesting that interference with actin dynamics leads to progressive degeneration of neurons. Together, these results further support the importance of AMPK in neuronal function and survival and provide a novel functional mechanisms how alterations in AMPK can cause neuronal degeneration
Ovarian cancer currently causes ~6,000 deaths per year in Germany alone. Since only palliative treatment is available for ovarian carcinomas that have developed resistance against platinum-based chemotherapy and paclitaxel, there is a pressing medical need for the development of new therapeutic approaches. As survival is strongly influenced by immunological parameters, immunotherapeutic strategies appear promising. The research of our group thus aims at overcoming tumour immune escape by counteracting immunosuppressive mechanisms in the tumour microenvironment. In this context, we found that tumour-infiltrating myeloid-derived suppressor cells (MDSC) or tumour associated macrophages (TAM) which are abundant in ovarian cancer express high levels of the enzyme 11β-hydroxysteroid dehydrogenase1 (11-HSD1). This oxido-reductase enzyme is essential for the conversion of biologically inactive cortisone into active cortisol. In line with this observation, high endogenous cortisol levels could be detected in serum, ascitic fluid and tumour exudates from ovarian cancer patients. Considering that cortisol exerts strong anti-inflammatory and immunosuppressive effects on immune cells, it appears likely that high endogenous cortisol levels contribute to immune escape in ovarian cancer. We thus hypothesised that local activation of endogenous glucocorticoids could suppress beneficial immune responses in the tumour microenvironment and thereby prevent a successful immunotherapy. To investigate the in vivo relevance of this postulated immune escape mechanism, irradiated PTENloxP/loxP loxP-Stop-loxP-krasG12D mice were reconstituted with hematopoietic stem cells from either glucocorticoid receptor (GR) expressing mice (GRloxP/loxP) or from mice with a T cell-specific glucocorticoid receptor knock-out (lck-Cre GRloxP/loxP) mice. In the host mice, the combination of a conditional PTEN knock-out with a latent oncogenic kras leads to tumour development when a Cre-encoding adenovirus is injected into the ovarian bursa. Using this model, mice that had been reconstituted with GC-insensitive T cells showed better intratumoural T cell infiltration than control mice that had received functionally unaltered GRloxP/loxP cells via adoptive transfer. However, tumour-infiltrating T cells mostly assumed a Foxp3+ (regulatory) phenotype and survival was even shortened in mice with cortisol-insensitive T cells. Thus, endogenous cortisol seems to inhibit immune cell infiltration in ovarian cancer, but productive anti-tumour immune responses might still be prevented by further factors from the tumour microenvironment. Thus, our data did not provide a sufficiently strong rationale to further pursue the antagonisation of glucocorticoid signalling in ovarian cancer patients, Moreover, glucocorticoids are frequently administered to cancer patients to reduce inflammation and swelling and to prevent chemotherapy-related toxic side effects like nausea or hypersensitivity reactions associated with paclitaxel therapy. Thus, we decided to address the question whether specific signalling pathways in innate immune cells, preferentially in NK cells, could still be activated even in the presence of GC. A careful investigation of the various activating NK cell receptors (i.e. NKp30, NKp44, NKp46), DNAM-1 and NKG2D) was thus performed which revealed that NKp30, NKp44 and NKG2D are all down-regulated by cortisol whereas NKp46 is actually induced by cortisol. Interestingly, NKp46 is the only known receptor that is strictly confined to NK cells. Its activation via crosslinking leads to cytokine release and activation of cytotoxic activity. Stimulation of NK cells via NKp46 may contribute to immune-mediated tumour destruction by triggering the lysis of tumour cells and by altering the cytokine pattern in the tumour microenvironment, thereby generating more favourable conditions for the recruitment of antigen-specific immune cells. Accordingly, our observation that even cortisol-treated NK cells can still be activated via NKp46 and CD2 might become valuable for the design of immunotherapies that can still be applied in the presence of endogenous or therapeutically administered glucocorticoids.
Recent development of proteomic approaches and generation of large-scale proteomic datasets calls for new methods for biological interpretation of the obtained results. Systems biological approaches such as integrated network analysis and functional module search have become an essential part of proteomic investigation. Proteomics is especially applied in anucleate cells such as platelets. The underlying molecular mechanisms of platelet activation and their pharmacological modulation are of immense importance for clinical research. Advances in platelet proteomics have provided a large amount of proteomic data, which has not yet been comprehensively investigated in a systems biological perspective. To this end, I assembled platelet specific data from proteomic and transcriptomic studies by detailed manual curation and worked on the generation of a comprehensive human platelet repository for systems biological analysis of platelets in the functional context of integrated networks (PlateletWeb) (http:/PlateletWeb.bioapps.biozentrum.uni-wuerzburg.de). I also added platelet-specific experimentally validated phosphorylation data and generated kinase predictions for 80% of the newly identified platelet phosphosites. The combination of drug, disease and pathway information with phosphorylation and interaction data makes this database the first integrative platelet platform available for platelet research. PlateletWeb contains more than 5000 platelet proteins, which can also be analyzed and visualized in a network context, allowing identification of all major signaling modules involved in platelet activation and inhibition. Using the wealth of integrated data I performed a series of platelet-specific analyses regarding the platelet proteome, pathways, drug targets and novel platelet phosphorylation events involved in crucial signaling events. I analyzed the statistical enrichment of known pathways for platelet proteins and identified endocytosis as a highly represented pathway in platelets. Further results revealed that highly connected platelet proteins are more often targeted by drugs. Using integrated network analysis offered by PlateletWeb, I analyzed the crucial activation signaling pathway of adenosine diphosphate (ADP), visualizing how the signal flow from receptors to effectors is maintained. My work on integrin inside-out signaling was also based on the integrated network approach and examined new platelet-specific phosphorylation sites and their regulation using kinase predictions. I generated hypothesis on integrin signaling, by investigating the regulation of Ser269 phosphorylation site on the docking protein 1 (DOK1). This phosphorylation site may influence the inhibiting effect of DOK1 on integrin a2bb3. Extending the integrated network approach to further cell lines, I used the assembled human interactome information for the analysis of functional modules in cellular networks. The investigation was performed with a previously developed module detection algorithm, which finds maximum-scoring subgraphs in transcriptomic datasets by using assigned values to the network nodes. We extended the algorithm to qualitative proteomic datasets and enhanced the module search by adding functional information to the network edges to concentrate the solution onto modules with high functional similarity. I performed a series of analyses to validate its performance in small-sized (virus-infected gastric cells) and medium-sized networks (human lymphocytes). In both cases the algorithm extracted characteristic modules of sample proteins with high functional similarity. The functional module search is especially useful in site-specific phosphoproteomic datasets, where kinase regulation of the detected sites is often sparse or lacking. Therefore, I used the module detection algorithm in quantitative phosphoproteomic datasets. In a platelet phosphorylation dataset, I presented a pipeline for network analysis of detected phosphorylation sites. In a second approach, the functional module detecting algorithm was used on a phosphoproteome network of human embryonic stem cells, in which nodes represented the maximally changing phosphorylation sites in the experiment. Additional kinases from the human phosphoproteome in PlateletWeb were included to the network to investigate the regulation of the signal flow. Results indicated important phosphorylation sites and their upstream kinases and explained changes observed in embryonic stem cells during differentiation. This work presents novel approaches for integrated network analysis in cells and introduces for the first time a systematic biological investigation of the human platelet proteome based on the platelet-specific knowledge base PlateletWeb. The extended methods for optimized functional module detection offer an invaluable tool for exploring proteomic datasets and covering gaps in complex large-scale data analysis. By combining exact module detection approaches with functional information data between interacting proteins, characteristic functional modules with high functional resemblance can be extracted from complex datasets, thereby focusing on important changes in the observed networks.
Schwermetallsalze wie beispielsweise Aluminium- oder Eisensalze werden in der Abwasserbehandlung zur Prävention und Bekämpfung von Blähschlamm, Schwimmschlamm und Schaumbildung verwendet. Dadurch kann eine Verbesserung der Schlammabsetzeigenschaften im Nachklärbecken erreicht werden. Übermäßiges Wachstum des grampositiven Bakteriums Microthrix parvicella gilt dabei als Hauptursache von Schlammabsetzproblemen und kann ebenfalls durch die Dosierung von schwermetallhaltigen Flockungs- und Fällungsmitteln vermieden werden. Da diese Verbindungen in Wasser gelöst sind, müssen sie die Außenmembran bestimmter Bakterien passieren. Nur der Einbau von wassergefüllten Kanälen erlaubt den gelösten Salzen das Passieren der durch hydrophobe Fettsäuren aufgebauten zusätzlichen Permeabilitätsbarriere. In dieser Arbeit wurden wassergefüllten Kanäle von Microthrix parvicella isoliert, aufgereinigt und mit Hilfe der Black-Lipid-Bilayer-Technik charakterisiert. Ergänzend wurde der Einfluss und der Durchlass der Flockungs- und Fällungsmittel in Titrationsexperimenten untersucht. Dabei konnte ein wassergefüllter Kanal, der die Bezeichnung MppA erhielt, gefunden werden, welcher eine Leitfähigkeit von 600 pS in 1 M Kaliumchlorid und eine Bindestelle für mehrwertige Kationen wie Eisen oder Aluminium zeigte. Die Bindung dieser mehrwertigen Kationen führte zu einer Änderung der Ionenselektivität. Ohne Bindung mehrwertiger Kationen zeigte der Kanal eine leichte Kationenselektivität. Nach der Bindung wechselte die Ionenselektivität zu einer Anionenselektivität, was auf eine spezifische Ladungsverteilung im Kanal hinweist. Der Kanal MppA zeigte gleichwertige Bindekonstanten für Aluminium und Eisen. Beide Metalle werden als Fällungs- und Flockungsmittel in Kläranlagen zum Verhindern von Schwimm- und Blähschlamm verwendet. Frühere Arbeiten offenbarten bereits, dass hauptsächlich der Aluminiumanteil entscheidend für die Wirkung dieser Mittel ist. Diese Beobachtungen in Verbindung mit den Ergebnissen dieser Arbeit führten zu der Annahme, dass Eisen und Aluminium eine kompetitive Bindung an der Bindestelle im Kanalinneren zeigen könnten. So könnte in manchen Fällen Aluminium anstelle des sonst als Spurenelement benötigten Eisens durch den Kanal transportiert werden und in Enzym-Substrat-Komplexen eingebaut werden. Dadurch könnten toxische Effekte auftreten, die letztlich ein Absterben des Organismus zur Folge hätten. Für die Bindung der Metallsalze konnte zusätzlich eine pH-Abhängigkeit beobachtet werden. Nur eine Zugabe von Metalllösungen mit einem pH-Wert kleiner 6 führte zu einer Bindung im Kanal. Die Zugabe von Metalllösungen mit einem pH-Wert größer 6 zeigte keinen Effekt auf die Leitfähigkeit des Kanals. Diese Ergebnisse bestätigen die auf Kläranlagen und in vorherigen Arbeiten getätigte Beobachtung, dass der pH-Wert für die Wirksamkeit der Verbindungen entscheidend ist. In dieser Arbeit konnte jedoch erstmals gezeigt werden, dass der pH-Wert direkt die Bindung der Metallsalze beeinflusst.
ATP dependent chromatin remodeling complexes are multifactorial complexes that utilize the energy of ATP to rearrange the chromatin structure. The changes in chromatin structure lead to either increased or decreased DNA accessibility. SWI/SNF is one of such complex. The SWI/SNF complex is involved in both transcription activation and transcription repression. The ATPase subunit of SWI/SNF is called SWI2/SNF2 in yeast and Brahma, Brm, in Drosophila melanogaster. In mammals there are two paralogs of the ATPase subunit, Brm and Brg1. Recent studies have shown that the human Brm is involved in the regulation of alternative splicing. The aim of this study was to investigate the role of Brm in pre-mRNA processing. The model systems used were Chironomus tentans, well suited for in situ studies and D. melanogaster, known for its full genome information. Immunofluorescent staining of the polytene chromosome indicated that Brm protein of C. tentans, ctBrm, is associated with several gene loci including the Balbiani ring (BR) puffs. Mapping the distribution of ctBrm along the BR genes by both immuno-electron microscopy and chromatin immunoprecipitation showed that ctBrm is widely distributed along the BR genes. The results also show that a fraction of ctBrm is associated with the nascent BR pre-mRNP. Biochemical fractionation experiments confirmed the association of Brm with the RNP fractions, not only in C. tentans but also in D. melanogaster and in HeLa cells. Microarray hybridization experiments performed on S2 cells depleted of either dBrm or other SWI/SNF subunits show that Brm affects alternative splicing and 3´ end formation. These results indicated that BRM affects pre-mRNA processing as a component of SWI/SNF complexes. 1
Many organisms evolved an endogenous clock to adapt to the daily environmental changes caused by the earth’s rotation. Light is the primary time cue (“Zeitgeber”) for entrainment of circadian clocks to the external 24-h day. In Drosophila, several visual pigments are known to mediate synchronization to light: The blue-light photopigment Cryptochrome (CRY) and six well-described rhodopsins (Rh1-Rh6). CRY is present in the majority of clock neurons as well as in the compound eyes, whereas the location of rhodopsins is restricted to the photoreceptive organs – the compound eyes, the ocelli and the HB-eyelets. CRY is thought to represent the key photoreceptor of Drosophila’s circadian clock. Nevertheless, mutant flies lacking CRY (cry01) are able to synchronize their locomotor activity rhythms to light-dark (LD) cycles, but need significantly longer than wild-type flies. In this behavior, cry01 mutants strongly resemble mammalian species that do not possess any internal photoreceptors and perceive light information exclusively through their photoreceptive organs (eyes). Thus, a mammalian-like phase-shifting behavior would be expected in cry01 flies. We investigated this issue by monitoring a phase response curve (PRC) of cry01 and wild-type flies to 1-h light pulses of 1000 lux irradiance. Indeed, cry01 mutants produced a mammalian-similar so called type 1 PRC of comparatively low amplitude (< 25% of wild-type) with phase delays to light pulses during the early subjective night and phase advances to light pulses during the late subjective night (~1 h each). Despite the predominant role of CRY, the visual system contributes to the light sensitivity of the fly’s circadian clock, mainly around dawn and dusk. Furthermore, this phase shifting allows for the slow re-entrainment which we observed in cry01 mutants to 8-h phase delays of the LD 12 h:12 h cycle. However, cry01 also showed surprising differences in their shifting ability: First of all, their PRC was characterized by a second dead zone in the middle of the subjective night (ZT17-ZT19) in addition to the usual unresponsiveness during the subjective day. Second, in contrast to wild-type flies, cry01 mutants did not increase their shift of activity rhythms neither in response to longer stimuli nor to light pulses of higher irradiance. In contrast, both 6-h light pulses of 1000 lux and 1-h light pulses of 10,000 lux light intensity during the early subjective night even resulted in phase advances instead of the expected delays. Thus, CRY seems to be not only responsible for the high light sensitivity of the wild-type circadian clock, but is apparently also involved in integrating and processing light information. Rhodopsin 7 (Rh7) is a yet uncharacterized protein, but became a good photoreceptor candidate due to sequence similarities to the six known Drosophila Rhs. The second part of this thesis investigated the expression pattern of Rh7 and its possible functions, especially in circadian photoreception. Furthermore, we were interested in a potential interaction with CRY and thus, tested cry01 and rh70 cry01 mutants as well. Rh1 is the main visual pigment of the Drosophila compound eye and expressed in six out of eight photoreceptors cells (R1-R6) in each of the ~800 ommatidia. Motion vision depends exclusively on Rh1 function but, moreover, Rh1 plays an important structural role and assures proper photoreceptor cell development and maintenance. In order to investigate its possible photoreceptive function, we expressed Rh7 in place of Rh1. Rh7 was indeed able to overtake the role of Rh1 in both aspects: It prevented retinal degeneration and mediated the optomotor response (OR), a motion vision-dependent behavior. At the transcriptional level, rh7 is expressed at approximately equal amounts in adult fly brains and retinas. Due to a reduced specificity of anti-Rh7 antibodies, we could not verify this result at the protein level. However, analysis of rh7 null mutants (rh70) suggested different Rh7 functions in vivo. Previous experiments strongly indicated an increased sensitivity of the compound eyes in the absence of Rh7 and suggested impaired light adaptation. We aimed to test this hypothesis at the levels of circadian photoreception. Locomotor activity rhythms are a reliable output of the circadian clock. Rh70 mutant flies generally displayed a wild-type similar bimodal activity pattern comprising morning (M) and evening (E) activity bouts. Activity monitoring supported the proposed “shielding” function, since rh70 mutants behaved like wild-type flies experiencing high irradiances. Under all investigated conditions, their activity peaks lay further apart resulting in a prolonged midday break. The behavior of cry01 mutants was mainly characterized by an unexpectedly high flexibility in the timing of M and E activity bouts which allowed tracking of lights-on and lights-off even under extreme photoperiods. Activity profiles of the corresponding rh70 cry01 double mutants reflected neither synergistic nor antagonistic effects of Rh7 and CRY and were dominated by a broad E activity peak. In the future, the different circadian phenotypes will be further investigated on the molecular level by analysis of clock protein cycling in the underlying pacemaker neurons. The work of this thesis confirmed that Rh7 is indeed able to work as a photoreceptor and to initiate the classical phototransduction cascade. On the other hand, it provided further evidence at the levels of circadian photoreception that Rh7 might serve as a shielding pigment for Rh1 in vivo, thereby mediating proper light adaptation.
The mechanisms that enable cells to regulate their gene expression and thus their metabolism, proliferation or cellular behaviour are not only important to understand the basic biology of a living cell, but are also of crucial interest in cancerogenesis. Highly interwoven and tightly regulated pathways are the basis of a robust but also flexible regulatory network. Interference with these pathways can be either causative for tumorigenesis or can modify its outcome. The receptor tyrosine kinase (RTK) and RAS dependent pathways leading to AKT or ERK1/2 activation are of particular interest in melanoma. These signaling modules are commonly activated by different mutations that can be found in various pathway components like NRAS, BRAF or PTEN. The first part of this work deals with the diverse and versatile functions of the ERK1/2 pathway feedbackregulator MKP2 in different cellular, melanoma relevant settings. In addition, a functional role of the AP1-complex member FOSL1, an ERK1/2 transcriptional target being implicated in the regulation of proliferation, is demonstrated. Secondly, aspects of direct pharmacological inhibition of the ERK1/2 pathway with regard to the induction of apoptosis have been analysed. Due to the high frequency of melanoma related mutations occurring in the RAS/RAF/MEK/ERK pathway (e.g. NRASQ61K, BRAFV600E), inhibition of this signaling cascade is deemed to be a promising therapeutic strategy for the treatment of malignant melanoma. However, although in clinical trials mono-therapeutic treatment with MEK- or RAF inhibitors was successful in the short run, it failed to show satisfactory long-lasting effects. Hence, combination therapies using a MAPK pathway inhibitor and an additional therapy are currently under investigation. I was able to demonstrate that inhibition of MEK using the highly specific inhibitor PD184352 can have a protective effect on melanoma cells with regard to their susceptibility towards the apoptosis inducing agent cisplatin. Single application of cisplatin led to strong DNA damage and the induction of caspase-dependent apoptosis. Additional administration of the MEK inhibitor, however, strongly reduced the apoptosis inducing effect of cisplatin in several melanoma cell lines, These cells displayed an increased activation of the serine/threonine kinase AKT after MEK inhibition. This AKT activation concomitantly led to the phosphorylation of FOXO transcription factors, attenuating the cisplatin induced expression of the BH3-only protein PUMA. PUMA in turn was important to mediate the apoptosis machinery after cisplatin treatment. My results also indicate a participation of RTKs, in particular EGFR, in mediating MEK inhibitor induced activation of AKT. These results demonstrate that inhibition of the RAS/RAF/MEK/ERK signaling pathway in melanoma cell lines does not necessilary have favourable effects in a cytotoxic co-treatment situation. Instead, it can even enhance melanoma survival under pro-apoptotic conditions.